Catalyst Wire Dossier Catalyst Wire Dossier

LYN101

· Shanghai TTM-Bio Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYN101, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 [Phase 1]

See pricing